20 May 2013
Keywords: uk, ok, femara, early, breast, cancer, medicines
Article | 12 December 2005
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of Swiss drug major Novartis' aromatase inhibitor
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 December 2005
17 May 2013
© 2013 thepharmaletter.com